Wellington Management Group’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-539,028
| Closed | -$3.25M | – | 2141 |
|
|
2019
Q4 | $3.25M | Buy |
+539,028
| New | +$3.12M | ﹤0.01% | 1438 |
|
|
2017
Q4 | – | Sell |
-1,918,197
| Closed | -$8.61M | – | 2347 |
|
|
2017
Q3 | $8.61M | Buy |
1,918,197
+114,295
| +6% | +$507K | ﹤0.01% | 1312 |
|
|
2017
Q2 | $8.28M | Buy |
1,803,902
+69,420
| +4% | +$279K | ﹤0.01% | 1272 |
|
|
2017
Q1 | $7.3M | Buy |
1,734,482
+64,049
| +4% | +$266K | ﹤0.01% | 1325 |
|
|
2016
Q4 | $6.9M | Sell |
1,670,433
-75,794
| -4% | -$403K | ﹤0.01% | 1307 |
|
|
2016
Q3 | $14.1M | Sell |
1,746,227
-32,106
| -2% | -$273K | ﹤0.01% | 1076 |
|
|
2016
Q2 | $13.9M | Sell |
1,778,333
-418,828
| -19% | -$3.59M | ﹤0.01% | 1062 |
|
|
2016
Q1 | $17M | Sell |
2,197,161
-1,032,550
| -32% | -$7.56M | ﹤0.01% | 974 |
|
|
2015
Q4 | $34.8M | Sell |
3,229,711
-7,647,125
| -70% | -$69.5M | 0.01% | 789 |
|
|
2015
Q3 | $75.2M | Buy |
10,876,836
+1,226,919
| +13% | +$10M | 0.02% | 536 |
|
|
2015
Q2 | $85.5M | Sell |
9,649,917
-485,453
| -5% | -$4.59M | 0.02% | 541 |
|
|
2015
Q1 | $99.9M | Buy |
10,135,370
+7,852,178
| +344% | +$98M | 0.03% | 508 |
|
|
2014
Q4 | $28M | Buy |
2,283,192
+2,075,892
| +1,001% | +$25.4M | 0.01% | 935 |
|
|
2014
Q3 | $2.07M | Buy |
207,300
+70,000
| +51% | +$650K | ﹤0.01% | 1674 |
|
|
2014
Q2 | $1.04M | Buy |
137,300
+73,300
| +115% | +$292K | ﹤0.01% | 1800 |
|
|
2014
Q1 | $211K | Sell |
64,000
-547,500
| -90% | -$1.92M | ﹤0.01% | 2108 |
|
|
2013
Q4 | $2.03M | Sell |
611,500
-165,500
| -21% | -$480K | ﹤0.01% | 1695 |
|
|
2013
Q3 | $2.35M | Sell |
777,000
-486,976
| -39% | -$3.34M | ﹤0.01% | 1634 |
|
|
2013
Q2 | $10.3M | Buy |
+1,263,976
| New | +$9.65M | ﹤0.01% | 1181 |
|
Wellington Management Group's ACHN Position: Q1 2020 in Review
Wellington Management Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 539,028 shares — an estimated $3.25M sold.
Wellington Management Group first reported a position in ACHN in Q2 2013 and held it in 19 quarters. The position peaked at $99.9M in Q1 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Wellington Management Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Wellington Management Group sold 539,028 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3.25M.
- Wellington Management Group first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 19 quarters.
- Wellington Management Group's Achillion Pharmaceuticals position peaked at $99.9M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.